dc.contributor.author | Melis, Valeria | |
dc.contributor.author | Magbagbeolu, Mandy | |
dc.contributor.author | Rickard, Janet E | |
dc.contributor.author | Horsley, David | |
dc.contributor.author | Davidson, Kathleen | |
dc.contributor.author | Harrington, Kathleen A | |
dc.contributor.author | Goatman, Keith | |
dc.contributor.author | Goatman, Elizabeth A | |
dc.contributor.author | Deiana, Serena | |
dc.contributor.author | Close, Steve P | |
dc.contributor.author | Zabke, Claudia | |
dc.contributor.author | Stamer, Karsten | |
dc.contributor.author | Dietze, Silke | |
dc.contributor.author | Schwab, Karima | |
dc.contributor.author | Storey, John M D | |
dc.contributor.author | Harrington, Charles R | |
dc.contributor.author | Wischik, Claude M | |
dc.contributor.author | Theuring, Franz | |
dc.contributor.author | Riedel, Gernot | |
dc.date.accessioned | 2015-05-28T13:53:03Z | |
dc.date.available | 2015-05-28T13:53:03Z | |
dc.date.issued | 2015-06 | |
dc.identifier | 49707505 | |
dc.identifier | 19712416-0276-4aee-b751-318801c69c61 | |
dc.identifier | 25769090 | |
dc.identifier | 84928393250 | |
dc.identifier.citation | Melis , V , Magbagbeolu , M , Rickard , J E , Horsley , D , Davidson , K , Harrington , K A , Goatman , K , Goatman , E A , Deiana , S , Close , S P , Zabke , C , Stamer , K , Dietze , S , Schwab , K , Storey , J M D , Harrington , C R , Wischik , C M , Theuring , F & Riedel , G 2015 , ' Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models ' , Behavioural Pharmacology , vol. 26 , no. 4 , pp. 353-368 . https://doi.org/10.1097/FBP.0000000000000133 | en |
dc.identifier.issn | 0955-8810 | |
dc.identifier.other | ORCID: /0000-0002-5261-5467/work/73579126 | |
dc.identifier.other | ORCID: /0000-0001-7063-7136/work/96652490 | |
dc.identifier.uri | http://hdl.handle.net/2164/4568 | |
dc.description | Acknowledgements The authors acknowledge the contributions of Bettina Seelhorst (histological analysis), Anna Thoma (animal care), Marlene Arthur (animal dosing) and Pierre-Henri Moreau (experimental discussions). This work was supported by TauRx Therapeutics Ltd., Singapore. | en |
dc.format.extent | 16 | |
dc.format.extent | 1029653 | |
dc.language.iso | eng | |
dc.relation.ispartof | Behavioural Pharmacology | en |
dc.subject | animal models | en |
dc.subject | learning and memory | en |
dc.subject | leucomethylithioninium | en |
dc.subject | methylene blue | en |
dc.subject | rat | en |
dc.subject | RotaRod | en |
dc.subject | taupathies | en |
dc.subject | water maze | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject.lcc | RM | en |
dc.title | Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1097/FBP.0000000000000133 | |